Bioglan AB
Simon Björklund is the Chief Executive Officer at Bioglan AB, a pharmaceutical company that offers a one-stop solution from product development to global sales. Prior to their current role, Simon had experience in business development and sales at Proffice Life Science, as well as research positions at Swedish University of Agricultural Sciences and Université Paul Sabatier. Simon holds a PhD in molecular biology/biotechnology from Umeå Plant Science Centre. With a background in research, business development, and teaching, Simon brings a diverse skill set to their current role in the pharmaceutical industry.
This person is not in any teams
Bioglan AB
Bioglan AB is a contract development and manufacturing organization with more than thirty years of experience in research, development, manufacturing and marketing of pharmaceuticals. We develop, produce and market pharmaceuticals and medical devices. We also provide support for pharmaceutical, healthcare and life science companies in all aspects of development and manufacturing of semi-solid and liquid products. We collaborate with companies of all sizes, from the smallest start-up to the leading pharmaceutical companies. Our manufacturing authorization from the Swedish Medical Products Agency allows us to produce non-sterile semi-solid and liquid products, both at pilot scale for clinical trials or at full-scale to supply a large commercial market. We can even be your QP release site for other types of products. Our quality system fulfils the EU and FDA GMP (Good Manufacturing Practice) requirements as well as the ISO 13485 standard for Medical Devices. Bioglan is a reliable, efficient and flexible organization that delivers projects with the best quality at the right time in a cost-effective way. We are proud that we meet the quality requirements of the global markets.